CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 55 enrolled
Drug / intervention
carboplatin +7 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00564733
NCT00564733Phase 2Completed
CompareCT.gov

FDG-PET Based Chemotherapy Selection for Metastatic Non-Small Cell Lung Cancer

University of Washington·interventional·Posted Nov 28, 2007·Updated Feb 10, 2017

In Brief

A Phase 2 clinical trial evaluating carboplatin, docetaxel, and 6 other interventions for Malignant Pleural Effusion and 2 related conditions. Completed, enrolled 55 participants across 2 sites.

Detailed Summary

This phase II trial studies how well fludeoxyglucose F 18 (FDG)-labeled positron emission tomography (PET) scan works in planning chemotherapy in treating patients with stage IIIB or IV non-small cell lung cancer (NSCLC). Drugs used in chemotherapy, such as paclitaxel, carboplatin, gemcitabine hydrochloride, and docetaxel, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Diagnostic imaging procedures, such as FDG-labeled PET scan, may help in guiding chemotherapy and allow doctors to plan better treatment

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMalignant Pleural Effusion, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 28, 2007
Enrollment StartOct 1, 2007
Primary CompletionSep 1, 2011
Study CompletionMar 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 18.6 years ago

Interventions

carboplatindrug

Given IV

docetaxeldrug

Given IV

gemcitabine hydrochloridedrug

Given IV

paclitaxeldrug

Given IV

computed tomographyprocedure

Undergo FDG PET/CT

positron emission tomographyprocedure

Undergo FDG PET/CT

fludeoxyglucose F 18radiation

Given IV

imaging biomarker analysisother

Correlative studies